275 related articles for article (PubMed ID: 31724937)
1. Epigenetic profiling of MUTYH, KLF6, WNT1 and KLF4 genes in carcinogenesis and tumorigenesis of colorectal cancer.
Babaei K; Khaksar R; Zeinali T; Hemmati H; Bandegi A; Samidoust P; Ashoobi MT; Hashemian H; Delpasand K; Talebinasab F; Naebi H; Mirpour SH; Keymoradzadeh A; Norollahi SE
Biomedicine (Taipei); 2019 Dec; 9(4):22. PubMed ID: 31724937
[TBL] [Abstract][Full Text] [Related]
2. DNA Methylation Profiling of MYC, SMAD2/3 and DNMT3A in Colorectal Cancer.
Norollahi SE; Foumani MG; Pishkhan MK; Shafaghi A; Alipour M; Jamkhaneh VB; Marghoob MN; Vahidi S
Oman Med J; 2021 Nov; 36(6):e315. PubMed ID: 34804598
[TBL] [Abstract][Full Text] [Related]
3. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
5. Fluctuations of epigenetic regulations in human gastric Adenocarcinoma: How does it affect?
Samadani AA; Noroollahi SE; Mansour-Ghanaei F; Rashidy-Pour A; Joukar F; Bandegi AR
Biomed Pharmacother; 2019 Jan; 109():144-156. PubMed ID: 30396071
[TBL] [Abstract][Full Text] [Related]
6. Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer.
Patnaik S; Anupriya
Front Pharmacol; 2019; 10():588. PubMed ID: 31244652
[TBL] [Abstract][Full Text] [Related]
7. A genomic screen for long noncoding RNA genes epigenetically silenced by aberrant DNA methylation in colorectal cancer.
Kumegawa K; Maruyama R; Yamamoto E; Ashida M; Kitajima H; Tsuyada A; Niinuma T; Kai M; Yamano HO; Sugai T; Tokino T; Shinomura Y; Imai K; Suzuki H
Sci Rep; 2016 May; 6():26699. PubMed ID: 27215978
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics and colorectal cancer pathogenesis.
Bardhan K; Liu K
Cancers (Basel); 2013 Jun; 5(2):676-713. PubMed ID: 24216997
[TBL] [Abstract][Full Text] [Related]
10. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
[TBL] [Abstract][Full Text] [Related]
11. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
Weisenberger DJ; Liang G; Lenz HJ
Oncogene; 2018 Feb; 37(5):566-577. PubMed ID: 28991233
[TBL] [Abstract][Full Text] [Related]
13. Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer.
Zhu Y; Lu H; Zhang D; Li M; Sun X; Wan L; Yu D; Tian Y; Jin H; Lin A; Gao F; Lai M
Clin Epigenetics; 2018; 10():30. PubMed ID: 29507648
[TBL] [Abstract][Full Text] [Related]
14. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of diacylglycerol kinase gamma in colorectal cancer.
Kai M; Yamamoto E; Sato A; Yamano HO; Niinuma T; Kitajima H; Harada T; Aoki H; Maruyama R; Toyota M; Hatahira T; Nakase H; Sugai T; Yamashita T; Toyota M; Suzuki H
Mol Carcinog; 2017 Jul; 56(7):1743-1752. PubMed ID: 28218473
[TBL] [Abstract][Full Text] [Related]
16. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
17. Chromatin remodeling agents for cancer therapy.
Dario LS; Rosa MA; Mariela E; Roberto G; Caterina C
Rev Recent Clin Trials; 2008 Sep; 3(3):192-203. PubMed ID: 18782077
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Alteration by DNA Promoter Hypermethylation of Genes Related to Transforming Growth Factor-β (TGF-β) Signaling in Cancer.
Khin SS; Kitazawa R; Kondo T; Idei Y; Fujimoto M; Haraguchi R; Mori K; Kitazawa S
Cancers (Basel); 2011 Mar; 3(1):982-93. PubMed ID: 24212650
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of microRNA expression in colorectal cancer.
Bandres E; Agirre X; Bitarte N; Ramirez N; Zarate R; Roman-Gomez J; Prosper F; Garcia-Foncillas J
Int J Cancer; 2009 Dec; 125(11):2737-43. PubMed ID: 19521961
[TBL] [Abstract][Full Text] [Related]
20. The role of epigenetics in colorectal cancer.
Coppedè F
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
